Abstract:IntroductionHDACs catalyze the removal of acetyl groups from the epsilon-N-acetylated lysine residues of various protein substrates including both histone and nonhistone proteins. Different HDACs have distinct biological functions and are recruited to specific regions of the genome. HDAC inhibitors have attracted much attention in recent decades; indeed, there have been more than thirty HDAC inhibitors investigated in clinic trials with five approvals being achieved.Areas coveredThis review covers the emerging approaches for HDAC inhibitor drug discovery from the past five years and includes discussion of structure-based rational design, isoform selectivity, and dual mechanism/multi-targeting. Chemical structures in addition to the in vitro and in vivo inhibiting activity of these compounds have also been discussed.Expert opinionThe exact role and biological functions of HDACs is still under investigation with a variety of HDAC inhibitors having been designed and evaluated. HDAC inhibitors have shown promise in treating cancer, AD, metabolic disease, viral infection, and multiple sclerosis, but there is still a lot of room for clinical improvement. In the future, more efforts should be put into (i) HDAC isoform identification (ii) the optimization of selectivity, activity, and pharmacokinetics; and (iii) unconventional approaches for discovering different effective scaffolds and pharmacophores.

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

Targeting the Zinc-Dependent Histone Deacetylases (HDACs) for Drug Discovery

Histone deacetylase complexes: Structure, regulation and function

Histone Deacetylases in Metabolism: The Known and the Unexplored

Targeting histone deacetylases: Emerging applications beyond cancer

Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.

A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity

The emerging roles of HDACs and their therapeutic implications in cancer

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy

Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors

A short guide to histone deacetylases including recent progress on class II enzymes

Recent Development of Novel HDAC6 Isoform-Selective Inhibitors.

An Update On The Emerging Approaches For Histone Deacetylase (Hdac) Inhibitor Drug Discovery And Future Perspectives

Roles of Histone Deacetylases in Epigenetic Regulation: Emerging Paradigms from Studies with Inhibitors

Technologies of Targeting Histone Deacetylase in Drug Discovery: Current Progress and Emerging Prospects.

Exploring the role of histone deacetylase inhibitors in cancer development and therapeutic potential

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases

The Zinc-Dependent HDACs: Non-Histone Substrates and Catalytic Deacylation Beyond Deacetylation.

The Structure and Function of Histone Deacetylases: the Target for Anti-cancer Therapy